Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. - Wikidata - wikimedia - TriplyDB

Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.

Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.

http://www.wikidata.org/entity/Q35190348

about

An update on the genetics of pheochromocytoma Connecting molecular pathways to hereditary cancer risk syndromes Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2 Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma Paragangliomas/Pheochromocytomas: clinically oriented genetic testing Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).SDHB-Associated Paraganglioma in a Pediatric Patient and Literature Review on Hereditary Pheochromocytoma-Paraganglioma Syndromes.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.Succinate dehydrogenase gene mutations in cardiac paragangliomas From arterial hypertension complications to von Hippel-Lindau syndrome diagnosis.New roles of carboxypeptidase E in endocrine and neural function and cancer.The genetic basis of pheochromocytoma and paraganglioma: implications for management Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma.Subclinical phaeochromocytoma.Phaeochromocytoma: a catecholamine and oxidative stress disorder.Pheochromocytoma - update on disease management.Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome.Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution.Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty.Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: focus on SDHB tumors.Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.Familial pheochromocytomas and paragangliomas.Pheochromocytomas and paragangliomas: assessment of malignant potential.Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.Pathophysiology and diagnosis of disorders of the adrenal medulla: focus on pheochromocytoma.Diagnosis and preoperative imaging of multiple endocrine neoplasia type 2: current status and future directions.

P2860

Q27024087-9F1D7089-2F73-413D-9EAD-385A531F7978 Q28291516-D0D81ED4-F7CC-4A2B-A644-12FFD0F353BD Q33587821-EF553344-90E0-4CA0-A675-FC5EF2249251 Q33587939-CDCA8426-D33C-4562-8507-3F49CC9667AC Q33590969-7E7D4007-DC82-46F0-9004-80B2FBFC7BD8 Q33679204-A84D4773-1A75-4A02-889E-29EF855A97D6 Q33846427-C8F0668C-D2A4-4D44-9EFE-245D41C2A46D Q33998937-1284CD86-2399-4E84-BC12-97B59BEF0486 Q34266352-ABDF956F-705A-41A1-9683-8F4F36ECDB1C Q34410500-F07A5833-1EEC-4AFE-BF49-912E2C2CC7DD Q34469783-6B77F801-F985-40A4-9DBD-D0381AF48018 Q34680693-46AA84BA-527A-4D81-ADF2-5DB9CE8CAD4E Q34921220-DAFAD637-EEA1-4902-B6FA-865EFA978CAC Q35160825-94F90AA8-59D8-4BB8-96B5-8F5C2E622944 Q35441891-96684D7B-2061-4293-91C0-22CE83DF911C Q35527336-DA25574A-E01C-4ED6-BAEF-43FCE5FA2F65 Q35562799-34EDCE85-18B8-4117-9B54-E4AEC81817B4 Q35668495-B978E907-8B3C-4AA4-927C-D9223D960861 Q35950916-4AFAA109-6DB8-4E21-996F-077B1366DEC7 Q36003395-E5966623-E832-4C04-832C-5613A7E60A09 Q36067684-E890B7D0-7156-4857-827F-C7DE3041E402 Q36090002-2A50A5AD-B8C8-4C2C-9868-9B6C63FF14AF Q36145100-7CEDB6FC-0711-4339-BEE7-463C3CFC186E Q36149357-DD00F358-65ED-404B-BC34-932E11CE6CBA Q36328071-FBA88783-A6AF-40D8-988A-34A2EA670D99 Q36339936-3A377926-4E4D-4D76-8554-B924D4227BF2 Q36408983-5C90E361-6B85-4F08-802C-EA5168F4C2CD Q36467102-5C3C6B6C-76F1-4D50-BF03-29E0BEF3EC9E Q36477785-47EDDCD2-1B30-416B-9E76-D568175FEC05 Q36625228-B98CFF0E-E7D7-4132-8721-373842790BD9 Q36730594-877C9886-652B-4D29-B915-24AD9CD5D184 Q36804496-FD024A00-0DAF-402B-A1D6-90D51303B583 Q37273892-41C6190E-F72A-48C6-A159-38832A056FC7 Q37464073-E3F4614F-2C7E-4CB0-984A-F4A1D464905D Q37568369-D5CFCC96-80CF-41EB-B0A8-CF65891D1261 Q37950920-068FB29F-5DF0-4E12-8E18-B87266779FF5 Q37969708-7B183ED5-FBE2-4E54-B0FB-EAEA9891D657 Q37994888-B2A4299C-8477-4010-B6E5-C9FBED2CCF8C Q38203226-42749DAC-A591-4BD1-B01F-3A3669EB9596 Q38217012-67486976-8707-42FC-B21B-BD2F9F200D14

P2860

Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.

http://www.wikidata.org/entity/Q35190348

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Measurements of plasma methoxy ...... ary forms of pheochromocytoma.

@ast

Measurements of plasma methoxy ...... ary forms of pheochromocytoma.

@en

type

label

Measurements of plasma methoxy ...... ary forms of pheochromocytoma.

@ast

Measurements of plasma methoxy ...... ary forms of pheochromocytoma.

@en

prefLabel

Measurements of plasma methoxy ...... ary forms of pheochromocytoma.

@ast

Measurements of plasma methoxy ...... ary forms of pheochromocytoma.

@en

P1433

Q35190348-0CA63220-74D1-45C9-9063-8462EB840A83

P1476

Q35190348-1836C63F-243D-48E4-AB15-77D19BDB3383

P2093

Q35190348-042E9D92-920D-4397-8C69-67D1FE117057

Q35190348-21DC1B31-B609-409A-93D7-96E905BF2D63

Q35190348-24AC230C-A205-4D48-9AF3-F1790DE69742

Q35190348-30CD389C-AAD0-4274-A3FF-BD93504984F5

Q35190348-3792B501-793F-4625-AFDB-0E6B79FA80AE

Q35190348-4C14B2FB-23AE-4CB5-BDC9-E0CFB1EF23EC

Q35190348-92C2ABD4-B28A-44AB-A6B3-1C4771641C4A

Q35190348-A9FA423F-9873-4AEC-8EA7-5DB031BBE991

Q35190348-EE408EA5-F62B-4466-B95E-3BA62504321A

Q35190348-FAE444AE-17B3-4A93-BF0B-2781EC16D731

P2860

Q35190348-0824D892-E010-4AF5-91BC-52F80DC7E683

Q35190348-0CF39CF1-E91A-44A8-8255-8463BC5AE08D

Q35190348-1818407E-E979-4F49-AD95-8AEF9FF0DB86

Q35190348-2007FE0D-D48C-4799-9BDE-46D1690ECCB1

Q35190348-3DF29C10-E1D4-4D8E-82A3-BF45C4F6FDC2

Q35190348-3E50A3ED-AF1C-447D-8F99-8760B63A0022

Q35190348-3F3F6233-B779-4424-AC91-181F837603D3

Q35190348-468FC644-760E-4CA4-A92C-21DECBCA54EA

Q35190348-57220C49-A382-4DF7-9823-477AB5B96916

Q35190348-60726E32-8EDC-48B0-951F-433279C6366B

P304

Q35190348-CC675892-D454-4A9E-A8AC-96FF4DA7864C

P31

Q35190348-4F9A92C0-2647-49C5-9217-759B6E691E30

P356

Q35190348-DCF4D611-875B-401F-9390-B5143C4229B9

P407

Q35190348-2B1E69C2-039B-43FB-995E-8B0962C34059

P433

Q35190348-DDB73DDF-BD60-4CC7-9B22-AC4536172A55

P478

Q35190348-AE1EA657-CA87-4A41-B417-C1F06AA61733

P50

Q35190348-1AEF5EA0-CE9F-4828-BA34-3CFF775118F3

Q35190348-968653B8-C66C-4499-B60D-3F9CA4D3B4A1

P577

Q35190348-4BB6E49A-2228-4A96-861E-6743EC4FC27F

P5875

Q35190348-20FD0BDA-75FD-49E1-AABD-FAC6BF01E660

P698

Q35190348-9E675DFC-AC2D-4140-BBA6-C7534F685B05

P921

Q35190348-1D660A70-FFAB-4B99-9468-A9AD69E155BF

P932

Q35190348-BCE5E653-C7D3-47C3-A240-B88B176C08A4

P356

CLINCHEM.2010.153320

P1433

Clinical Chemistry

P1476

Measurements of plasma methoxy ...... ary forms of pheochromocytoma.

@en

P2093

Gennady Bratslavsky

http://www.w3.org/2001/XMLSchema#string

Graeme Eisenhofer

http://www.w3.org/2001/XMLSchema#string

Henri Timmers

http://www.w3.org/2001/XMLSchema#string

Jacques W M Lenders

http://www.w3.org/2001/XMLSchema#string

Karen Adams

http://www.w3.org/2001/XMLSchema#string

Lorenz C Hofbauer

http://www.w3.org/2001/XMLSchema#string

Massimo Mannelli

http://www.w3.org/2001/XMLSchema#string

Oliver Tiebel

http://www.w3.org/2001/XMLSchema#string

Stefan K Grebe

http://www.w3.org/2001/XMLSchema#string

W Marston Linehan

http://www.w3.org/2001/XMLSchema#string

P2860

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

Biochemical diagnosis of pheochromocytoma: which test is best?

High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing

Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes

SDHA is a tumor suppressor gene causing paraganglioma.

SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.

Germ-line mutations in nonsyndromic pheochromocytoma.

Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas.

Genetics of pheochromocytoma and paraganglioma in Spanish patients.

Pheochromocytoma: the expanding genetic differential diagnosis.

P304

411-420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2010.153320

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Stefan R. Bornstein

P577

2011-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49781661

http://www.w3.org/2001/XMLSchema#string

P698

21262951

http://www.w3.org/2001/XMLSchema#string

P921

phaeochromocytoma

P932

3164998

http://www.w3.org/2001/XMLSchema#string